跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
GARDASIL 9 SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
GARDASIL 9 SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Merck Sharp & Dohme B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 22, 2022
Approval ID
9018a643d103174b
Company
Merck Sharp & Dohme B.V.
Type
Standard
Approval Details
Approval Id
9018a643d103174b
Drug Cima Aemps Name
GARDASIL 9 SUSPENSION INYECTABLE EN JERINGA PRECARGADA
Register Number
151007002IP
Holder Company Name
Merck Sharp & Dohme B.V.
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/merck-sharp-and-dohme-bv
Authorization Date
2022-09-22
Dosage Form
SUSPENSIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
0,5 ml
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Merck Sharp & Dohme B.V.
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Company Information
Pharmaceutical Company Name
Merck Sharp & Dohme BV
Country Name
Netherlands
Active Ingredients
VIRUS PAPILOMA HUMANO TIPO 16 PROTEINA L1
IP IP
VIRUS PAPILOMA HUMANO TIPO 6 PROTEINA L1
IP IP
VIRUS PAPILOMA HUMANO TIPO 18 PROTEINA L1
IP IP
VIRUS PAPILOMA HUMANO TIPO 11 PROTEINA L1
IP IP
VIRUS PAPILOMA HUMANO TIPO 31 PROTEINA L1
IP IP
VIRUS PAPILOMA HUMANO TIPO 33 PROTEINA L1
IP IP
VIRUS PAPILOMA HUMANO TIPO 45 PROTEINA L1
IP IP
VIRUS PAPILOMA HUMANO TIPO 52 PROTEINA L1
IP IP
VIRUS PAPILOMA HUMANO TIPO 58 PROTEINA L1
IP IP
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 22, 2022
Approval ID
9018a643d103174b
Type
Standard
Back to CIMA-AEMPS Approvals
GARDASIL 9 SUSPENSION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
